Navigation Links
Scientists Report Clues to Flu Shot's Effectiveness
Date:3/13/2013

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, March 13 (HealthDay News) -- Flu vaccines protect people by activating white blood cells that, in turn, boost the development of antibodies to the flu, a new study suggests.

The finding may lead to more effective vaccines -- especially for people whose immune system isn't robust enough to fully protect them from the flu, such as the elderly, the study authors said.

"It is well known that CD4 T cells are important for the generation of antibody responses," said lead researcher Dr. Hideki Ueno, an investigator at the Baylor Institute for Immunology Research in Dallas.

"Most importantly, we found that the appearance of these cells in blood correlated with the development of protective antibodies against flu. Therefore, these cells appear to be very important for the successful flu vaccination," he said.

The failure of older people to generate a protective antibody response after a flu vaccine might be associated with the failure to produce these CD4 T cells, Ueno said.

This year, for example, the flu vaccine was only 9 percent effective in older people against the dominant H3N2 strain, according to the U.S. Centers for Disease Control and Prevention. Finding ways to boost a vaccine's effectiveness is especially important for seniors, who are at higher risk of complications from the flu and are more likely to die from them.

One way to help high-risk people might be to identify those whose immune response is likely to be insufficient to fully protect them from the flu, the researchers said.

"You could potentially screen people for their antibody response -- particularly young children and the elderly," said Andrea Sant, a professor with the department of microbiology and immunology at the University of Rochester, in Rochester, N.Y.

This screening could also be important during flu pandemics, said Sant, who was not involved with the study. "You could find out if a dose is sufficient to protect people and those who might need a boost," she added.

Sant said using these CD4 T cells might also be a way of making vaccines more effective.

"Theoretically, you could fine-tune vaccines so they could allow people to have more of these cells in their body when they get a vaccine, either by adding them to a vaccine or administering them before a vaccination," she explained.

The new study was published online March 13 in the journal Science Translational Medicine.

Looking at small groups of children and adults, the researchers found a special type of CD4 T cells that appear after receiving a flu shot. Specifically, these CD4 T cells have three components -- called CXCR5, CXCR3 and ICOS -- that are the key to boosting the immune response to a flu vaccine, the study authors reported.

These so-called "helper cells" aid what are called "memory" B cells to make antibodies to the flu. What these memory cells are remembering is having seen a flu strain before and knowing how to react by making antibodies, the researchers explained.

So, in older people who have a lot of these memory cells, boosting CD4 T cells might help memory cells to respond and launch an immune defense, the investigators suggested.

"Therefore, it would be very beneficial and important to understand the mechanisms by which these cells develop in humans. These studies might lead to the development of more effective vaccines for flu and other diseases," Ueno said.

Another infectious diseases expert, Dr. Marc Siegel, clinical associate professor at NYU Langone Medical Center in New York City, added, "If you could boost this process you could boost immunity, and this could help the elderly who have an impaired immune response."

More information

For more on the flu vaccine, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: Hideki Ueno, M.D., Ph.D., investigator, Baylor Institute for Immunology Research, Dallas; Andrea Sant, Ph.D., professor, department of microbiology and immunology, University of Rochester, Rochester, N.Y.; Marc Siegel, M.D., clinical associate professor of medicine, NYU Langone Medical Center, New York City; March 13, 2013, Science Translational Medicine, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Scientists discuss relationship between abortion and violence against women
2. A*STAR scientists discover switch critical to wound healing
3. Scientists uncover source of ovarian stem-like cells prone to give rise to ovarian cancer
4. Defective virus surprisingly plays major role in spread of disease, UCLA life scientists report
5. OHSU scientists first to grow liver stem cells in culture, demonstrate therapeutic benefit
6. Scientists Pinpoint How Deep Brain Stimulation Eases OCD
7. Scientists make older adults less forgetful in memory tests
8. Scientists unveil secrets of important natural antibiotic
9. Fungi offers new clues in asthma fight, say Cardiff scientists
10. Scientists find promising new approach to preventing progression of breast cancer
11. Hopkins scientists create method to personalize chemotherapy drug selection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... The Anaheim Hills ... customers. First National Capital has added 10 new sales professionals over the past 6 ... positions by 15 additional new hires over the course of 2017. , “This ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center will ... April 3rd to commemorate the two-year anniversary of the facility. The event will ... two great years while also familiarizing themselves with the facility. , In the ...
(Date:3/26/2017)... Columbus, Ohio (PRWEB) , ... March 26, 2017 ... ... 100 doctors worldwide to receive the RealSelf 100 Award, a prestigious award honoring ... elective cosmetic procedures and to find and connect with doctors and clinics. , ...
(Date:3/24/2017)... ... 2017 , ... Vighter established its NAEMT Authorized Training Center ... Trauma Life Support (PHTLS) course scholarships to four medics assigned to the Minnesota ... cooperation with the American College of Surgeons to promote critical thinking in addressing ...
(Date:3/24/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) has named ... in their 12th year, are among the most prestigious in radiology marketing because a ... were retooled to recognize achievements in both large budget (over $5,000) and small budget ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... FRANCISCO , March 27, 2017 ... expected to reach USD 16.0 billion by 2025, according ... The growing prevalence of chronic diseases is anticipated to ... chemistry analyzers, which thereby widens the scope for growth ... geriatric and bariatric population, which is highly susceptible to ...
(Date:3/27/2017)...  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its ... as Impax,s President and Chief Executive Officer and ... 2017. Mr. Bisaro will succeed J. Kevin Buchi ... Executive Officer since December of 2016. ... Mr. Bisaro, 56, is an accomplished global business leader ...
Breaking Medicine Technology: